# A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

> **NCT06804811** · PHASE3 · RECRUITING · sponsor: **Incyte Corporation** · enrollment: 250 (estimated)

## Conditions studied

- NonSegmental Vitiligo

## Interventions

- **DRUG:** Ruxolitinib Cream
- **DRUG:** Vehicle Cream

## Key facts

- **NCT ID:** NCT06804811
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-13
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-12-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06804811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06804811, "A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06804811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*